<DOC>
	<DOCNO>NCT00503009</DOCNO>
	<brief_summary>This study last 9 week . Subjects visit clinic 14 time . Certain clinic visit include physical examination , lung function test , inflammatory cell analysis nasal secretion and/or sputum , blood draw . Subjects inhale FDA approve virus nose know cause common cold . All study relate medication medical examination provide cost subject . The drug use study approve age group study .</brief_summary>
	<brief_title>Study Of RV-39 In Patients Who Also Have Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Have asthma least 3 month prior study . Have use allow prestudy asthma therapy least 3 month prior study . Demonstrate airway hyperresponsiveness follow inhalation bronchoconstrictor . Have positive allergic status antibody test . Have history lifethreatening asthma . Been hospitalize asthma within 24 month prior study . Have certain condition would make study participation unsafe . The study doctor evaluate inclusion exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Rhinovirus</keyword>
	<keyword>Asthma</keyword>
</DOC>